Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning
    Open Access
    Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning
    Carlos Vinícius Gomes, Yizhou Chen, Isabel Rauscher, Song Xue, Andrei Gafita, Jiaxi Hu, Robert Seifert, Lorenzo Mercolli, Julia Brosch-Lenz, Jimin Hong, Marc Ryhiner, Sibylle Ziegler, Ali Afshar-Oromieh, Axel Rominger, Matthias Eiber, Thiago Viana Miranda Lima and Kuangyu Shi
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 778-784; DOI: https://doi.org/10.2967/jnumed.124.268175
  • Diagnostic Potential of <sup>68</sup>Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease
    You have access
    Diagnostic Potential of 68Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease
    Zahra Sabahi, Andrew Nguyen, Keith Wong, Sherrington Li, Nathan Papa, Elgene Lim, Rachel F. Dear, Alexander M. Menzies, Frances Boyle, Yoland Antill, Belinda E. Kiely, Benjamin C. Forster, Cindy Mak, Diana Adams, Lina Pugliano, Andrew Spillane, Shikha Sharma, Adam Hickey, Aron Poole, Shikha Agrawal, Sobia Khan, Narjess Ayati and Louise Emmett
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 700-706; DOI: https://doi.org/10.2967/jnumed.124.268896
  • Dansylated Amino Acid–Modified Long-Acting PSMA Derivatives <sup>68</sup>Ga/<sup>177</sup>Lu-LNC1011 as Prostate Cancer Theranostics
    You have access
    Dansylated Amino Acid–Modified Long-Acting PSMA Derivatives 68Ga/177Lu-LNC1011 as Prostate Cancer Theranostics
    Hongzhang Yang, Jiarou Wang, Xuejun Wen, Huifeng Guo, Vivianne Jakobsson, Tianzhi Zhao, Fantian Zeng, Huaxiang Shen, Heng Zhang, Xiaomin Liu, Yatong Qin, Xinyi Li, Hehe Xiong, Zijian Zhou, Jingjing Zhang and Xiaoyuan Chen
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 739-747; DOI: https://doi.org/10.2967/jnumed.124.268959
  • Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in the proPSMA Study
    You have access
    Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study
    David C. Chen, James P. Buteau, Louise Emmett, Ramin Alipour, Felipe de Galiza Barbosa, Matthew J. Roberts, Aoife McVey, Jonathan O’Brien, Sidney Levy, Roslyn J. Francis, Nathan Lawrentschuk, Declan G. Murphy and Michael S. Hofman
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 713-718; DOI: https://doi.org/10.2967/jnumed.124.268901
  • <sup>18</sup>F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis
    You have access
    18F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis
    Ashwin Singh Parihar, Sofia Vaz, Siobhan Sutcliffe, Niharika Pant, Jan W. Schoones and Gary A. Ulaner
    Journal of Nuclear Medicine May 1, 2025, 66 (5) 692-699; DOI: https://doi.org/10.2967/jnumed.124.269163
  • Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients
    You have access
    Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients
    Maria Giovanna Trivieri, Ana Devesa, Philip M. Robson, Sonali Bose, Busra Cangut, Steve Liao, Audrey Kaufman, Renata Pyzik, Valentin Fauveau, Jamie Wood, Aaron Shpiner, Edwin Yoo, Sarayu Huang, Claudia Calcagno, Venkatesh Mani, Sahityasri Thapi, Johanna Contreras, Kai Nie, Seunghee Kim-Schulze, Sacha Gnjatic, Miriam Merad, Munir Ghesani, David Putrino, Adam Jacobi, Donna Mancini, Charles Powell and Zahi A. Fayad
    Journal of Nuclear Medicine April 30, 2025, jnumed.124.268980; DOI: https://doi.org/10.2967/jnumed.124.268980
  • CD70-Targeted [<sup>18</sup>F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
    You have access
    CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study
    Binyu Shi, You Zhang, Shuo Wu, Dongsheng Xu, Qianyun Wu, Wenzhi Jia, Shuxian An, Cheng Wang, Yongrui Bai, Jianjun Liu, Junjun Zhou and Weijun Wei
    Journal of Nuclear Medicine April 30, 2025, jnumed.125.269585; DOI: https://doi.org/10.2967/jnumed.125.269585
  • A Phase I/II Study of [<sup>177</sup>Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol
    You have access
    A Phase I/II Study of [177Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol
    Sara Harsini, Maryam Soleimani, Don Wilson, Carlos Uribe, Heather Saprunoff, Ingrid Bloise and Francois Benard
    Journal of Nuclear Medicine April 30, 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064
  • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [<sup>177</sup>Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
    You have access
    Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
    Gunjan Kayal, Molly E. Roseland, Chang Wang, Kellen Fitzpatrick, David Mirando, Krithika Suresh, Ka Kit Wong and Yuni K. Dewaraja
    Journal of Nuclear Medicine April 24, 2025, jnumed.124.269389; DOI: https://doi.org/10.2967/jnumed.124.269389
  • [<sup>18</sup>F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies
    Open Access
    [18F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies
    Joachim Brumberg, Nils Schröter, Ganna Blazhenets, M. Aymen Omrane, Christian Volz, Cornelius Weiller, Michel Rijntjes, Lars Frings, Sabine Hellwig, Wolfgang H. Jost and Philipp T. Meyer
    Journal of Nuclear Medicine April 17, 2025, jnumed.124.268956; DOI: https://doi.org/10.2967/jnumed.124.268956

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 91
SNMMI

© 2025 SNMMI

Powered by HighWire